EHA 2025 | Advancing CAR-T therapy for patients with hematological malignancies
Yajing Zhang
• 13 Jun 2025
In this interview, Yajing Zhang, MD, Beijing Gobroad Boren Hospital, Beijing, China, discusses approaches being explored to maximize the benefit of CAR T-cell therapy for patients with hematological malignancies, sharing studies presented at EHA 2025. This video is provided courtesy of TalkMED, in collaboration with Magdalen Medical Publishing (MMP). The interview was recorded at the 30th Congress of the European Hematology Association (EHA) in Milan, Italy.
These works are protected by copyright laws and treaties around the world. All rights are reserved.
